G. Hasbal Et Al. , "Identification of AKT1/CTNNB1 mutations conferring cetuximab and chemotherapeutic drugs resistance in colorectal cancer treatment," 2nd Eurosia Biochemical Approaches and Technologies Congress , Antalya, Turkey, 2019
Hasbal, G. Et Al. 2019. Identification of AKT1/CTNNB1 mutations conferring cetuximab and chemotherapeutic drugs resistance in colorectal cancer treatment. 2nd Eurosia Biochemical Approaches and Technologies Congress , (Antalya, Turkey).
Hasbal, G., Aksoy Sağırlı, P., & Can, A., (2019). Identification of AKT1/CTNNB1 mutations conferring cetuximab and chemotherapeutic drugs resistance in colorectal cancer treatment . 2nd Eurosia Biochemical Approaches and Technologies Congress, Antalya, Turkey
Hasbal, Gözde, Pınar AKSOY SAĞIRLI, And Ayşe CAN. "Identification of AKT1/CTNNB1 mutations conferring cetuximab and chemotherapeutic drugs resistance in colorectal cancer treatment," 2nd Eurosia Biochemical Approaches and Technologies Congress, Antalya, Turkey, 2019
Hasbal, Gözde H. Et Al. "Identification of AKT1/CTNNB1 mutations conferring cetuximab and chemotherapeutic drugs resistance in colorectal cancer treatment." 2nd Eurosia Biochemical Approaches and Technologies Congress , Antalya, Turkey, 2019
Hasbal, G. Aksoy Sağırlı, P. And Can, A. (2019) . "Identification of AKT1/CTNNB1 mutations conferring cetuximab and chemotherapeutic drugs resistance in colorectal cancer treatment." 2nd Eurosia Biochemical Approaches and Technologies Congress , Antalya, Turkey.
@conferencepaper{conferencepaper, author={Gözde HASBAL ÇELİKOK Et Al. }, title={Identification of AKT1/CTNNB1 mutations conferring cetuximab and chemotherapeutic drugs resistance in colorectal cancer treatment}, congress name={2nd Eurosia Biochemical Approaches and Technologies Congress}, city={Antalya}, country={Turkey}, year={2019}}